Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid
- PMID: 860891
- DOI: 10.1001/archpsyc.1977.01770170055004
Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid
Abstract
Lumbar cerebrospinal fluid homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and probenecid were measured in four subgroups of neuropsychiatrically disturbed children and a contrast group of pediatric patients. With the exception of a serotonin metabolite difference between autistic and nonautistic psychotic children, there were no significant differences in metabolite concentrations among autistic, nonautistic psychotic, aphasic, and cognitively and attentionally impaired groups, or between the developmentally disabled and contrast groups of children. Younger children had higher concentrations of HVA than older children. Girls had significantly lower HVA/probenecid ratios than boys, which did not appear to be related to underlying neuropsychiatric disorder. Significant probenecid-metabolite correlations indicate the importance of measuring probenecid in the cerebrospinal fluid in clinical studies.
Similar articles
-
Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.Arch Gen Psychiatry. 1974 Dec;31(6):845-53. doi: 10.1001/archpsyc.1974.01760180085011. Arch Gen Psychiatry. 1974. PMID: 4441252 No abstract available.
-
Cerebrospinal fluid probenecid studies: a reinterpretation.Biol Psychiatry. 1983 Nov;18(11):1287-99. Biol Psychiatry. 1983. PMID: 6197100 Review.
-
CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.Arch Gen Psychiatry. 1980 Jun;37(6):677-81. doi: 10.1001/archpsyc.1980.01780190075009. Arch Gen Psychiatry. 1980. PMID: 6155891
-
CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report.J Pediatr. 1977 Jan;90(1):67-71. doi: 10.1016/s0022-3476(77)80766-x. J Pediatr. 1977. PMID: 830896
-
Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.Brain Res. 1974 Oct 11;79(1):1-8. doi: 10.1016/0006-8993(74)90562-9. Brain Res. 1974. PMID: 4279131 Review. No abstract available.
Cited by
-
Overview of selected basic research in autism.J Autism Dev Disord. 1979 Jun;9(2):199-218. doi: 10.1007/BF01531534. J Autism Dev Disord. 1979. PMID: 225298
-
Clinical neurochemistry of autism and associated disorders.J Autism Dev Disord. 1982 Jun;12(2):147-65. doi: 10.1007/BF01531305. J Autism Dev Disord. 1982. PMID: 6184361 Review.
-
Inhibition of the Beta-oxidation Pathway of Fatty Acids and Dopamine- Beta-hydroxylase by Phenyl Derivatives of Short- Chain Fatty Acids from Gastrointestinal Clostridia Bacteria is a (the) Major Cause of Autism.Integr Med (Encinitas). 2023 May;22(2):18-25. Integr Med (Encinitas). 2023. PMID: 37363147 Free PMC article.
-
Autism and lactic acidosis.J Autism Dev Disord. 1985 Mar;15(1):1-8. doi: 10.1007/BF01837894. J Autism Dev Disord. 1985. PMID: 3980425
-
Dopamine-beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children.J Autism Dev Disord. 1986 Mar;16(1):23-9. doi: 10.1007/BF01531575. J Autism Dev Disord. 1986. PMID: 3957856
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources